Compounds > phenylpropanolamine
Page last updated: 2024-08-16

phenylpropanolamine and HIV Coinfection

phenylpropanolamine has been researched along with HIV Coinfection in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Case, P; Chintalova-Dallas, R; Kitsenko, N; Lazzarini, Z1
Bradley, TP; de la Fuente, M; Khurana, V1

Other Studies

2 other study(ies) available for phenylpropanolamine and HIV Coinfection

ArticleYear
Boltushka: a homemade amphetamine-type stimulant and HIV risk in Odessa, Ukraine.
    The International journal on drug policy, 2009, Volume: 20, Issue:4

    Topics: Adult; Amphetamines; Central Nervous System Stimulants; Drug Compounding; Female; HIV Infections; Humans; Male; Pharmacies; Phenylpropanolamine; Propiophenones; Risk-Taking; Substance Abuse, Intravenous; Ukraine

2009
Hypertensive crisis secondary to phenylpropanolamine interacting with triple-drug therapy for HIV prophylaxis.
    The American journal of medicine, 1999, Volume: 106, Issue:1

    Topics: Adult; Anti-HIV Agents; Clemastine; Drug Synergism; Female; Histamine H1 Antagonists; HIV Infections; Humans; Hypertension; Nasal Decongestants; Nonprescription Drugs; Phenylpropanolamine

1999